LIPUM AB Alternatives & Competitors
12 companies similar to LIPUM AB — We have developed a biological drug SOL-116 for treatment of chronic inflammator...
Companies similar to LIPUM AB
Connect Biopharma
Global Clinical Stage Company Connecting Patients with Innovation for Life
Revolo Biotherapeutics
Analyze | Reset | Revolutionize
Akari Therapeutics, Plc
Advancing Next-Generation Antibody Drug Conjugates Designed with Novel ImmunoOncology Payl...
SetPoint Medical
Regulating Inflammation - through the nervous system
Rival Readout
Competing with LIPUM AB? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Evommune
Developing innovative therapies that target key drivers of chronic inflammatory diseases.
Upstream Bio
Developing treatments for inflammatory diseases
ADARx Pharmaceuticals Inc.
Our vision is to provide effective and safe RNA therapeutics to patients who suffer from i...
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
Vantage Biosciences
Transforming diabetic eye disease with an oral treatment
About LIPUM AB
LIPUM AB, a trailblazer in the Biotechnology and Health Care sectors, has developed SOL-116, a groundbreaking biological drug targeting chronic inflammatory diseases. Since its inception in 2010, the company has been committed to improving the quality of life for millions affected by these debilitating conditions, sign...
Development of anti-inflammatory drugs, Clinical development and trials of SOL-116, Scientific advisory and consultancy
Patients with chronic inflammatory diseases, Healthcare providers, Medical researchers, Investors in life sciences
Biological Drug Development, Chronic Inflammatory Diseases, Rheumatoid Arthritis Treatment, Juvenile Idiopathic Arthritis, Orphan Drug Designation, Autoimmune Diseases, Novel Mechanism Of Action, Preclinical Research, Pediatric Rare Diseases, Health Care Cost Reduction, Ankylosing Spondylitis, Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis, Drug Candidate Development
B2B, B2D
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around LIPUM AB: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at LIPUM AB on 14 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.